KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 57 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,094 | +27.2% | 33,972 | +3.1% | 0.00% | – |
| Q2 2023 | $463,978 | +44.3% | 32,953 | +10.3% | 0.00% | – |
| Q1 2023 | $321,530 | +2300.9% | 29,882 | +3242.5% | 0.00% | – |
| Q4 2022 | $13,392 | -16.3% | 894 | -26.5% | 0.00% | – |
| Q3 2022 | $16,000 | +6.7% | 1,217 | -20.6% | 0.00% | – |
| Q2 2022 | $15,000 | -61.5% | 1,532 | -60.7% | 0.00% | – |
| Q1 2022 | $39,000 | -76.5% | 3,894 | -72.4% | 0.00% | – |
| Q4 2021 | $166,000 | -23.1% | 14,123 | -25.4% | 0.00% | – |
| Q3 2021 | $216,000 | -52.5% | 18,925 | -42.0% | 0.00% | – |
| Q2 2021 | $455,000 | -79.5% | 32,636 | -72.7% | 0.00% | – |
| Q1 2021 | $2,216,000 | +73.7% | 119,693 | +65.7% | 0.00% | – |
| Q4 2020 | $1,276,000 | +68.8% | 72,215 | +46.2% | 0.00% | – |
| Q3 2020 | $756,000 | -26.2% | 49,403 | +22.9% | 0.00% | – |
| Q2 2020 | $1,024,000 | +582.7% | 40,186 | +314.7% | 0.00% | – |
| Q1 2020 | $150,000 | +74.4% | 9,690 | +23.8% | 0.00% | – |
| Q4 2019 | $86,000 | +30.3% | 7,828 | +0.1% | 0.00% | – |
| Q3 2019 | $66,000 | -33.3% | 7,821 | +7.0% | 0.00% | – |
| Q2 2019 | $99,000 | -59.4% | 7,308 | -46.0% | 0.00% | – |
| Q1 2019 | $244,000 | -10.6% | 13,528 | +38.9% | 0.00% | – |
| Q4 2018 | $273,000 | +1087.0% | 9,741 | +962.3% | 0.00% | – |
| Q3 2018 | $23,000 | – | 917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |